Substance / Medication

Ergotamine tartrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans.
Armer T A, Shrewsbury S B, Newman S P et al. · Curr Med Res Opin · 2007
PMID: 17991308Observational
An unusual cause of chest pain: Acute coronary syndrome following administration of ergotamine tartrate.
Okutucu Sercan, Karakulak Ugur Nadir, Kabakcı Giray et al. · Exp Clin Cardiol · 2012
PMID: 23204901Case ReportFull text (PMC)
Dihydroergotamine Tartrate Induces Lung Cancer Cell Death through Apoptosis and Mitophagy.
Chang Seung-Hee, Lee Ah Young, Yu Kyeong-Nam et al. · Chemotherapy · 2016
PMID: 27100100Other
Contractile Response of Bovine Lateral Saphenous Vein to Ergotamine Tartrate Exposed to Different Concentrations of Molecularly Imprinted Polymer.
Kudupoje Manoj B, Klotz James L, Yiannikouris Alexandros et al. · Toxins (Basel) · 2018
PMID: 29385697PreclinicalFull text (PMC)
Embryo development and survival in beef cattle administered ergotamine tartrate to simulate fescue toxicosis.
Schuenemann Gustavo M, Hockett Mitch E, Edwards J Lannett et al. · Reprod Biol · 2005
PMID: 16100563Preclinical
Effects of administration of ergotamine tartrate on fertility of yearling beef bulls.
Schuenemann Gustavo M, Edwards J Lannett, Davis Mark D et al. · Theriogenology · 2005
PMID: 15725447Preclinical
Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs.
Tsutsumi Keiko, Obata Yasuko, Nagai Tsuneji et al. · Int J Pharm · 2002
PMID: 11996820Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ergotamine tartrate (substance)
SNOMED CT
396046007
UMLS CUI
C0086248

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.